Delta Financial Advisors LLC Sells 572 Shares of CVS Health Co. (NYSE:CVS)

Delta Financial Advisors LLC trimmed its holdings in CVS Health Co. (NYSE:CVS) by 1.8% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 31,748 shares of the pharmacy operator’s stock after selling 572 shares during the quarter. Delta Financial Advisors LLC’s holdings in CVS Health were worth $2,507,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. Live Oak Investment Partners bought a new stake in CVS Health during the 4th quarter worth about $25,000. Atticus Wealth Management LLC raised its holdings in CVS Health by 149.0% during the 4th quarter. Atticus Wealth Management LLC now owns 366 shares of the pharmacy operator’s stock worth $29,000 after purchasing an additional 219 shares during the last quarter. Cornerstone Planning Group LLC raised its holdings in CVS Health by 111.5% during the 3rd quarter. Cornerstone Planning Group LLC now owns 461 shares of the pharmacy operator’s stock worth $32,000 after purchasing an additional 243 shares during the last quarter. ZRC Wealth Management LLC raised its holdings in CVS Health by 400.0% during the 4th quarter. ZRC Wealth Management LLC now owns 500 shares of the pharmacy operator’s stock worth $39,000 after purchasing an additional 400 shares during the last quarter. Finally, True Wealth Design LLC bought a new stake in CVS Health during the 4th quarter worth about $48,000. 80.66% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other CVS Health news, EVP Prem S. Shah sold 29,473 shares of the company’s stock in a transaction that occurred on Friday, February 16th. The stock was sold at an average price of $76.95, for a total transaction of $2,267,947.35. Following the completion of the transaction, the executive vice president now owns 39,765 shares of the company’s stock, valued at approximately $3,059,916.75. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 0.24% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have weighed in on CVS shares. SVB Leerink started coverage on CVS Health in a report on Monday, February 26th. They set an “outperform” rating and a $88.00 price objective for the company. Leerink Partnrs reaffirmed an “outperform” rating on shares of CVS Health in a research note on Monday, February 26th. StockNews.com cut CVS Health from a “buy” rating to a “hold” rating in a research note on Thursday, February 15th. Barclays began coverage on CVS Health in a research note on Wednesday, March 6th. They issued an “equal weight” rating and a $78.00 price target for the company. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $87.00 price target on shares of CVS Health in a research note on Wednesday, April 10th. Four research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $89.44.

CVS Health Stock Up 1.0 %

Shares of CVS traded up $0.66 on Thursday, hitting $69.26. The company’s stock had a trading volume of 3,292,574 shares, compared to its average volume of 10,799,277. The company has a quick ratio of 0.63, a current ratio of 0.86 and a debt-to-equity ratio of 0.77. The firm’s fifty day moving average price is $75.53 and its 200-day moving average price is $73.73. CVS Health Co. has a fifty-two week low of $64.41 and a fifty-two week high of $83.25. The firm has a market capitalization of $87.30 billion, a price-to-earnings ratio of 10.71, a P/E/G ratio of 0.91 and a beta of 0.52.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, February 7th. The pharmacy operator reported $2.12 earnings per share for the quarter, topping analysts’ consensus estimates of $2.01 by $0.11. CVS Health had a return on equity of 15.25% and a net margin of 2.33%. The firm had revenue of $93.81 billion during the quarter, compared to the consensus estimate of $90.58 billion. During the same quarter in the prior year, the firm posted $1.99 EPS. The business’s revenue was up 11.9% on a year-over-year basis. On average, equities research analysts expect that CVS Health Co. will post 8.32 EPS for the current year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 1st. Shareholders of record on Monday, April 22nd will be given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 3.84%. The ex-dividend date is Friday, April 19th. CVS Health’s dividend payout ratio (DPR) is currently 41.18%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.